Source: Annals of Diagnostic Pathology. Unidades: FO, FM
Subjects: CARCINOMA, PROTEÍNAS PROTO-ONCOGÊNICAS
ABNT
MARTINS, Mariana Bonjiorno et al. Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions. Annals of Diagnostic Pathology, v. 53, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.anndiagpath.2021.151766. Acesso em: 22 ago. 2024.APA
Martins, M. B., Batista, F. de A., Marcello, M. A., Bufalo, N. E., Peres, K. C., Morari, E. C., et al. (2021). Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions. Annals of Diagnostic Pathology, 53. doi:10.1016/j.anndiagpath.2021.151766NLM
Martins MB, Batista F de A, Marcello MA, Bufalo NE, Peres KC, Morari EC, Soares FA, Vassallo J, Ward LS. Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions [Internet]. Annals of Diagnostic Pathology. 2021 ; 53[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.anndiagpath.2021.151766Vancouver
Martins MB, Batista F de A, Marcello MA, Bufalo NE, Peres KC, Morari EC, Soares FA, Vassallo J, Ward LS. Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions [Internet]. Annals of Diagnostic Pathology. 2021 ; 53[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.anndiagpath.2021.151766